- Home
- CHRS vs ORMP Comparison
CHRS vs ORMP Comparison
Compare CHRS & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- ORMP
- Stock Information
- Founded
- CHRS 2010
- ORMP 2002
- Country
- CHRS United States
- ORMP United States
- Employees
- CHRS N/A
- ORMP N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- CHRS Health Care
- ORMP Health Care
- Exchange
- CHRS Nasdaq
- ORMP Nasdaq
- Market Cap
- CHRS 94.0M
- ORMP 84.3M
- IPO Year
- CHRS 2014
- ORMP N/A
- Fundamental
- Price
- CHRS $0.91
- ORMP $2.20
- Analyst Decision
- CHRS Strong Buy
- ORMP Hold
- Analyst Count
- CHRS 4
- ORMP 1
- Target Price
- CHRS $5.38
- ORMP N/A
- AVG Volume (30 Days)
- CHRS 2.1M
- ORMP 99.0K
- Earning Date
- CHRS 05-08-2025
- ORMP 03-27-2025
- Dividend Yield
- CHRS N/A
- ORMP N/A
- EPS Growth
- CHRS N/A
- ORMP N/A
- EPS
- CHRS 0.25
- ORMP N/A
- Revenue
- CHRS $266,959,999.00
- ORMP N/A
- Revenue This Year
- CHRS N/A
- ORMP N/A
- Revenue Next Year
- CHRS $9.02
- ORMP N/A
- P/E Ratio
- CHRS $3.66
- ORMP N/A
- Revenue Growth
- CHRS 3.78
- ORMP N/A
- 52 Week Low
- CHRS $0.66
- ORMP $1.96
- 52 Week High
- CHRS $2.61
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- CHRS 45.16
- ORMP 43.45
- Support Level
- CHRS $0.89
- ORMP $2.06
- Resistance Level
- CHRS $1.07
- ORMP $2.40
- Average True Range (ATR)
- CHRS 0.09
- ORMP 0.09
- MACD
- CHRS -0.00
- ORMP -0.03
- Stochastic Oscillator
- CHRS 44.79
- ORMP 35.00
About CHRS Coherus BioSciences Inc.
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline which includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.